Hsing‐Pang Hsieh

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide

Chang‐Jer Wu, Jia-Tsrong Jan, Chi-Min Chen et al. · Antimicrobial Agents and Chemotherapy · 2004 · 253 citations · Full text

Antiviral Agents, Respiratory Diseases, Niclosamide Concentration +10

Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3)

Chia-Nan Chen, Coney P. C. Lin, Kuo-Kuei Huang et al. · Evidence-based Complementary and Alternative Medicine · 2005 · 244 citations · Full text

BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity<b><i>in Vivo</i></b>

Ching‐Chuan Kuo, Hsing‐Pang Hsieh, Wen-Yu Pan et al. · Cancer Research · 2004 · 198 citations

Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease

I-Lin Lu, Neeraj Mahindroo, Po‐Huang Liang et al. · Journal of Medicinal Chemistry · 2006 · 171 citations · Full text

Concise Synthesis and Structure−Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents

Jing‐Ping Liou, Yi-Ling Chang, Fu‐Ming Kuo et al. · Journal of Medicinal Chemistry · 2004 · 155 citations · Full text